Kukicha

Synopsis

Kukicha (Twig Tea): A Comprehensive Reference

1. Identity and Nomenclature

Botanical and Common Names

Kukicha (茎茶), or twig tea, also known as bōcha (棒茶), is a Japanese tea blend made of stems, stalks, and twigs of the tea plant. It is made from Camellia sinensis, which is the same species used to produce all true teas; the botanical name sinensis is a compound meaning "from China" in Botanical Latin. The synonym Thea sinensis L. appears in older literature and in some regulatory documents. The plant belongs to the family Theaceae.

The term kukicha literally means "twig tea," where the root "cha" stands for tea and "kuki" for twigs. It is available as a green tea or in more oxidized processing.

Regional Varieties and Synonyms

Several distinct regional designations apply to kukicha based on the source material and geography:

When coming from gyokuro's production, it takes the name karigane (雁ヶ音). Karigane has historically been the name of kukicha made from leaves used for gyokuro green tea; however, these days the term karigane has become diverse and is also used for any kukicha of high quality. Karigane that is specifically from Kyushu is called shiraore.
In Kyushu, particularly in areas like Yame, it is known as shiraore (白折), or "white fold," referring to the pale, folded appearance of the stems from first-flush or shaded teas.
From Ishikawa Prefecture (historically called Kaga), a roasted form is termed kaga-bōcha (加賀棒茶), or "Kaga stick tea," where the name combines the regional identifier kaga with bōcha to emphasize its origin and twig-based material.

Distinction from Leaf Teas

Kukicha is a traditional Japanese green tea made primarily from the stems, twigs, and sometimes leaf veins of the Camellia sinensis plant, rather than whole leaves. Kukicha has a unique flavour and aroma among teas, due to it being composed of parts of the plant that are excluded from most other teas. Regular kukicha material comes from production of sencha or matcha. When coming from gyokuro's production, it takes the name karigane.

2. Natural Source and Production

Plant Source

Camellia sinensis is a woody shrub or tree that is typically 1 to 5 m tall; it is usually trimmed to a height of about 1 m with a flat top when in commercial tea plantations.

Derivation as a By-Product

Kukicha is not a primary product but arises as a by-product of the refinement of other fine Japanese teas, particularly during the processing of sencha, gyokuro, and matcha. When the stems and twigs are separated from the leaves during the "refinement" process called "Shiagecha," these "secondary" components give life to kukicha, transforming what was once considered waste into a product of value.

The production process involves separating the thicker stems and twigs from harvested tea leaves using machines that filter by weight and size, resulting in a blend with a varying stem-to-leaf ratio depending on the source tea.

Types of Stem Material

Traditional preparations may incorporate several distinct clipping types. One production approach uses four different clippings: the first from three-year-old, semi-wild plants, from which twigs from the under part of the bush are trimmed in autumn; the second consists of thick twigs harvested every ten years, usually in mid-winter, when the caffeine level is at its lowest; the third and fourth clippings, done every year in March and June, consist of small, thin twigs, stems, and mature brown dried leaves.

Processing Methods

Two major processing paths exist. The plant parts are steamed, rolled, and dried similarly to other Japanese green teas. In an alternative roasted form, bōcha is a type of kukicha made by roasting the stems until they become a brownish-red color, and is especially famous in the Kanazawa area of Ishikawa Prefecture.

To produce some varieties of kukicha, the Camellia sinensis branches are dried and then allowed to age for around two years. The process is finished by steaming and then gently roasting the kukicha. The traditional method includes four separate roastings in wood-fired, iron cauldrons, which slowly develops the distinctive flavor and aroma. This style of tea is a specialty of Japanese tea makers, not commonly found in other tea cultures.

Visually, in unroasted varieties the components appear as light green to pale stems, while roasted variants such as bōcha exhibit a darker brown hue due to the heating process.

Common Commercial Forms

Loose-leaf (unroasted green): stems and twigs processed by steaming and drying, yielding a pale yellow-green infusion.
Roasted (bōcha/kaga-bōcha): stems roasted to a brownish-red colour, producing an amber or earthy brown infusion.
Tea bags: commercially available but generally considered inferior by producers, as the irregular twig material does not translate well to the teabag format.
Karigane: distinguished by its source plant — stems from shaded tea plants (gyokuro or matcha-grade) — which gives it elevated L-theanine and sweetness.

3. Historical and Traditional Use

Origins in Japan

The history of kukicha is rooted in the Uji region of Japan, an area historically renowned for tea cultivation. Its origins are deeply tied to Japanese farming culture and represent an example of the ingenuity and sustainability philosophy intrinsic to Japanese tradition.

This practice likely gained prominence during the Edo period (1603–1868), when sencha production expanded rapidly and the removal of coarser stems became standard to refine the quality of leaf teas for market appeal. Rather than wasting these by-products, they were dried, sorted, and sometimes roasted to create a distinct, milder tea accessible to everyday drinkers.

Kukicha's cultural inception is deeply intertwined with Japan's broader tea history, which began with the importation of tea cultivation techniques from China in the 12th century, but the specific emphasis on stems and twigs for tea-making represents a uniquely Japanese innovation. The term "kukicha" derives from "kuki" meaning stems or twigs and "cha" meaning tea, reflecting this resourceful approach to the plant's lesser-used parts.

Social and Economic Context

Initially, kukicha was perceived as a "farmer's drink" or a "second-choice option." Its production arose from the use of stems and twigs discarded during the processing of more prestigious teas like sencha and gyokuro. The farmers, who often could not afford the expensive high-quality teas they produced for sale, found in these "leftovers" an economical and sustainable way to prepare their daily infusions.

Stems from matcha production — too hard to grind and called oremono — were utilized by the general populace, evolving into a recognized variety known as shiraore for its lighter-colored stems.

Evolution into Wider Recognition

Kukicha gained prominence in Japan during the 19th and 20th centuries, evolving from a humble beverage consumed by lower socioeconomic classes to a more widely appreciated tea, particularly as mechanized processing techniques emerged in the 1910s and became standard by the 1930s. Its popularity surged internationally in the mid-20th century through the promotion of macrobiotic diets, with founder George Ohsawa introducing it to the West around 1970 as a low-caffeine option for balancing bodily acidity and supporting health.

George Ohsawa (born Nyoichi Sakurazawa; October 18, 1893 – April 23, 1966) was a Japanese author and proponent of alternative medicine who was the founder of the macrobiotic diet. Ohsawa, along with his disciple Michio Kushi, popularized the drink in the West. It plays a central role in the macrobiotic diet, which is based on the belief that balance is the key to optimum well-being. The macrobiotic diet consists of mostly whole grains, fruits, and vegetables, legumes, and seaweed, with kukicha as one of the recommended beverages.

Kukicha tea was popularized in the U.S. and Europe in the 1960s by George Ohsawa. Ohsawa considered kukicha to be the perfect beverage for a grain-based, or mostly vegetarian, diet.

Traditional Preparation Methods

For best results, kukicha is traditionally steeped in water between 70 and 80 °C (158 and 176 °F). Green varieties are best steeped for less than one minute. For roasted varieties, water up to 90 °C can also be used, as the roasting makes the tea less sensitive to high temperatures. An infusion time of 2–3 minutes is recommended to achieve a balanced flavor.

In the macrobiotic tradition, a decoction method was favored: simmering over low heat for 5–10 minutes to enhance minerals and the alkalizing effect; the traditional macrobiotic recipe involves boiling one teaspoon of twigs per cup for approximately 2.5 minutes over low heat, with a maximum of three cups per day recommended.

4. Key Constituents and Active Compounds

General Chemical Profile

Like other teas from Camellia sinensis, kukicha contains a mix of caffeine, amino acids, catechins, flavonoids, and trace minerals. But because kukicha uses stems and stalks rather than mostly leaf tissue, the balance of these compounds shifts.

Modern composition work on tea stems suggests that stems tend to carry less caffeine and fewer catechins than leaves, while offering more free amino acids and soluble sugars. That helps explain why kukicha is often smoother, softer, and less bitter than many leaf-heavy green teas.

Catechins (Polyphenols)

Green tea is rich in many polyphenols, including flavanols, flavandiols, flavonoids, and phenolic acids. The major components of green tea polyphenols are flavanols (or catechins), of which the most abundant are (−)-epigallocatechin-3-gallate (EGCG), (−)-epicatechin (EC), (−)-epicatechin-3-gallate (ECG), and (−)-epigallocatechin (EGC). EGCG forms more than 50% of all green tea catechins, representing about 16.5% of the water-extractable fraction of tea.

Because kukicha is derived from stems rather than leaves, its catechin content is notably lower than that of leaf-based teas. Bitterness in green tea comes primarily from catechins (especially EGCG) and caffeine, both of which are concentrated in the leaves. Because kukicha uses stems, both compounds are present at much lower levels, resulting in a forgiving, easy-to-brew cup that almost never turns harsh even when slightly over-steeped. Compared to other Japanese green teas, kukicha contains a relatively higher level of theanine and a lower level of catechin.

L-Theanine

L-theanine is a non-proteinogenic amino acid that is notably elevated in kukicha relative to leaf teas. L-theanine is more concentrated in the stems because it is produced in the roots and transported through the stem, while in the leaves, photosynthesis causes its conversion into catechins. Because the stems and twigs do not face sunlight as much as the leaves, the high level of theanine remains intact. As a matter of fact, theanine is found in double the amount in the stems and twigs compared to in leaves.

Biochemically, L-theanine is a water-soluble, non-proteinogenic amino acid with a molecular structure similar to that of glutamic acid. L-theanine can cross the blood–brain barrier within 30 minutes after ingestion in humans, and the maximum plasma concentrations occur 30–120 minutes after administration, with complete clearance from plasma within 24 hours.

Caffeine

Stems have been shown in studies to carry approximately half the caffeine content of tea leaves, and they also contain less catechin. Kukicha typically contains 20 to 40 mg of caffeine per serving. During the autumn and winter months, the caffeine level in the stems is at its lowest.

Minerals

The stems and woody parts of the plant accumulate different minerals than leaves do. Kukicha is notably high in calcium (much more so than leaf teas), as well as potassium, iron, and fluoride. This is the origin of its reputation as a calcium-rich tea — a claim that has nutritional basis, though the amount in a cup is modest compared to dairy sources.

Kukicha is particularly rich in essential minerals such as calcium, magnesium, potassium, and fluoride. These minerals play vital roles in supporting bodily functions, from bone health to cardiovascular wellness.

Other Compounds

Additional polyphenols identified in green tea include catechin (C), epicatechin (EC), gallocatechin (GC), gallocatechin gallate (GCG), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate (EGCg). In addition, caffeine, theobromine, theophylline, and phenolic acids such as gallic acid are also present as constituents of green tea in smaller quantities. Kukicha, derived from stems, carries these compounds at lower concentrations relative to leaf-based preparations. Among the Japanese types of green tea infusions, kukicha is recognized alongside mecha, genmaicha, kamairicha, and others as a distinct category.

Mechanism of Action: L-Theanine and Caffeine Synergy

Available scientific studies indicate that L-theanine significantly modifies the effects of caffeine, reducing its stimulant effect, positively affecting brain function, improving cognitive functions, mood and concentration, and additionally decreasing blood pressure.

The possible mechanisms of action of L-theanine in the central nervous system involve several targets. Among these, L-theanine inhibits glutamate reuptake and confers a neuroprotective effect by binding to gamma-aminobutyric acid (GABA_A) receptors. L-theanine acts as a weak antagonist of glutamate on the AMPA and modulates the NMDA receptors.

Mechanism of Action: Catechins and Antioxidant Activity

EGCG possesses a wide variety of anti-inflammatory, antioxidant, antifibrotic, anti-remodeling, and tissue-protective properties which may be useful in the treatment of various diseases, particularly in cancer, and neurological, cardiovascular, respiratory, and metabolic disorders.

The bulk of evidence has shown that the cardioprotective activity of green tea is mainly attributed to the antioxidant properties of its catechins, which act by inducing anti-oxidant enzymes, inhibiting pro-oxidant enzymes, and scavenging free radicals.

5. Scientific Evidence by Area of Use

Important methodological caveat: Much of the evidence comes from green tea and tea-compound research more broadly, not from kukicha-specific clinical trials. That makes honest, evidence-aware use especially important. No large-scale clinical trials to date have been conducted using kukicha as a specific intervention. The evidence below, drawn from studies of Camellia sinensis constituents (particularly EGCG, catechins, and L-theanine), is applicable to kukicha insofar as it shares those constituents — but at lower concentrations than found in standard green tea infusions.

5.1 Cognitive Function, Mood, and Stress

Evidence strength: Preliminary to moderate; small human RCTs with largely positive results, but heterogeneous and requiring replication.

A randomized, placebo-controlled, crossover, double-blind trial aimed to examine the possible effects of four weeks of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults. Participants were 30 individuals (nine men and 21 women; mean age 48.3 ± 11.9 years) who had no major psychiatric illness. L-theanine (200 mg/day) or placebo tablets were randomly and blindly assigned for four-week administration.

For stress-related symptoms, Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index (PSQI) scores decreased after L-theanine administration. The PSQI subscale scores for sleep latency, sleep disturbance, and use of sleep medication also reduced after L-theanine administration, compared to the placebo administration.

In a systematic review published in 2019 by Williams et al., L-theanine in its pure form at a daily dose of 200–400 mg reduced stress and anxiety in people under acute stress.

A 2024–2025 systematic review and meta-analysis of RCTs published in PMC examined the cognitive effects of L-theanine more broadly. L-theanine has been used to improve cognition and mood, but although the effects of L-theanine on cognition have been investigated in clinical trials reporting various results, these studies have not yet been critically and uniformly evaluated. One placebo-controlled trial found that L-theanine treatment (200 mg) was associated with a significant reduction in baseline anxiety as assessed by the "tranquil-troubled" item of the Bond–Lader visual analogue scales, while no evidence of reduction in experimentally-induced anxiety was found.

A 28-day randomized, double-blind, placebo-controlled trial found that L-theanine supplementation significantly decreased perceived stress, improved sleep quality, and enhanced cognitive attention in the studied population. The investigators noted that larger, randomized controlled trials with longer duration are warranted to reduce inter-individual variability and the potential placebo effect.

The mechanistic link between kukicha and these effects rests on its elevated L-theanine content relative to other teas. However, given that clinical studies use isolated L-theanine at doses of 200–400 mg — doses unlikely to be achieved through normal kukicha consumption at standard brewing volumes — direct extrapolation from these trials to kukicha as a beverage requires caution.

5.2 Cardiovascular Health

Evidence strength: Moderate from observational and meta-analytic data on green tea; interventional RCT evidence for lipid and blood pressure effects is also present but effect sizes are modest.

A bulk of observational studies have revealed the protective role of green tea supplementation in cardiovascular diseases. A systematic review and meta-analysis examined the effects of green tea supplementation on cardiovascular risk factors including lipid profile, blood pressure, glycemic control markers, and CRP.

Among 55 eligible RCTs with 63 effect sizes, results from the random-effects meta-analysis showed that green tea extract (GTE) supplementation significantly reduced total cholesterol (WMD = −7.62; 95% CI: −10.51, −4.73), LDL-C (WMD = −5.80; 95% CI: −8.30, −3.30), fasting blood sugar (WMD = −1.67; 95% CI: −2.58, −0.75), HbA1c (WMD = −0.15; 95% CI: −0.26, −0.04), and diastolic blood pressure (WMD = −0.87; 95% CI: −1.45, −0.29), while increasing HDL-C (WMD = 1.85; 95% CI: 0.87, 2.84).

A meta-analysis of 38 prospective cohort data sets from 27 papers, incorporating 1,956,549 participants, found that the pooled effect estimates of the highest versus lowest categories of tea consumption were 0.90 (95% CI, 0.86 to 0.95) for all-cause mortality and 0.86 (95% CI, 0.79 to 0.94) for CVD mortality. Cancer mortality showed a trend (RR 0.90) but the confidence interval crossed 1.0, meaning statistical significance was not established.

These cardiovascular findings apply to green tea broadly and are driven primarily by catechin content. Because kukicha contains lower catechin levels than standard green tea infusions, these effect sizes cannot be assumed to transfer directly.

5.3 Antioxidant and Anti-inflammatory Effects

Evidence strength: Mechanistic basis is well-established at the molecular level; human clinical evidence for disease prevention remains preliminary.

The cancer-preventive effects of EGCG are widely supported by results from epidemiological, cell culture, animal, and clinical studies. EGCG is a known antioxidant compound; it is proposed that this flavonoid suppresses the inflammatory processes that lead to transformation, hyperproliferation, and initiation of carcinogenesis. Green tea polyphenols inhibit cell proliferation and exert a strong antiradical activity.

EGCG possesses anti-inflammatory, antioxidant, antifibrotic, anti-remodeling, and tissue-protective properties, which may be useful in the treatment of various diseases, particularly cancer, and neurological, cardiovascular, respiratory, and metabolic disorders. These mechanistic properties derive primarily from in vitro and animal studies; robust human clinical evidence for kukicha-derived antioxidant outcomes specifically is absent.

5.4 Metabolic Health and Glycemic Control

Evidence strength: Moderate for green tea catechins in human RCTs; kukicha-specific evidence does not exist.

Among RCTs included in a 2022 meta-analysis, green tea extract supplementation significantly reduced fasting blood sugar (WMD = −1.67 mg/dL) and HbA1c (WMD = −0.15%), both reaching statistical significance. Subgroup analyses based on the duration of supplementation (≥12 vs. <12 weeks), dose of GTE (≥1,000 vs. <1,000 mg/day), and sex demonstrated different results for some risk factors, underscoring the heterogeneity of this evidence base.

5.5 Mineral Contribution: Bone and Dental Health

Evidence strength: Observational and nutritional basis for mineral content claims; no clinical intervention trials exist for kukicha specifically.

The stems and woody parts of the plant accumulate different minerals than leaves do. Kukicha is notably high in calcium, potassium, iron, and fluoride. The calcium content claim has a nutritional basis, though the amount in a cup is modest compared to dairy sources.

The stems and twigs of kukicha absorb a high level of minerals — like calcium, magnesium, potassium, and fluoride — making it potentially supportive of bone and dental health. No controlled human intervention trials have evaluated kukicha's effect on bone mineral density or dental health as an outcome.

5.6 Alkalizing Properties

Evidence strength: Claimed primarily within the macrobiotic tradition; not supported by peer-reviewed human clinical trials.

Kukicha tea has become a staple of the macrobiotic diet due to its alkalizing properties and low caffeine content. The "alkalizing" property of kukicha is a central concept within the macrobiotic tradition introduced by George Ohsawa, who framed it as a balancing beverage for grain-based diets. This framing reflects a cultural-dietary philosophy rather than a clinically validated physiological mechanism. No peer-reviewed clinical trials have examined the effect of kukicha on urinary or blood pH in human subjects.

6. Body Systems and Health Areas Associated with Kukicha

Central nervous system / neurocognitive: Via L-theanine's interaction with GABA_A, AMPA, and NMDA receptors; clinical L-theanine RCTs show modest positive effects on stress, anxiety, and sleep at 200–400 mg/day doses.
Cardiovascular: Via catechin-mediated antioxidant, anti-inflammatory, and lipid-modulating effects documented in green tea RCTs and cohort meta-analyses.
Metabolic / glycemic: Via EGCG and catechin effects on insulin sensitivity and fasting glucose, as documented in green tea intervention studies.
Musculoskeletal / bone: Via mineral content (calcium, magnesium, fluoride), with nutritional basis but no kukicha-specific intervention data.
Dental health: Via fluoride and tannin content; the mineral matrix of kukicha may contribute to prevention of cavities due to fluoride and tannins with action against oral bacteria.
Antioxidant / cellular protection: Via EGCG and polyphenols; mechanistic evidence strong at molecular level, human clinical evidence from kukicha specifically absent.

7. Dosage Forms and Reported Dosages

Kukicha is consumed almost exclusively as an aqueous infusion (tea). No pharmaceutical or standardized supplement preparations specific to kukicha are recognized in major pharmacopeias. The following dosage parameters are drawn from traditional brewing guidance and constituent-level clinical research:

Brewing Guidelines (Infusion)

Depending on the size of the brewing vessel, 4–8 g of kukicha tea with filtered or spring water heated to 70–85 °C is used; steep for 1–3 minutes depending on preference.
Kukicha, mainly made of stems, branches, and leaf veins, is less sensitive to higher water temperatures and longer steeping times compared to other green teas.
Kukicha twigs can be reused for 2–3 subsequent infusions, especially high-quality green kukicha, with slightly increased steeping times for each subsequent infusion.
Cold brew method: Add 5 g to 500 ml of cold water and refrigerate overnight (8–12 hours).
Macrobiotic decoction method: simmer over low heat for 5–10 minutes; traditional macrobiotic recipe: one teaspoon of twigs per cup for approximately 2.5 minutes; maximum of three cups per day.

Constituent Dosages Used in Clinical Research

The following doses were used in clinical trials examining kukicha's key constituents (not kukicha itself):

L-theanine: 200 mg/day for four weeks in a crossover RCT of stress-related symptoms and cognitive function.
L-theanine (stress/anxiety): 200–400 mg/day in a systematic review of studies examining acute stress.
Green tea extract (cardiovascular RCTs): Dose subgroups of ≥1,000 mg/day vs. <1,000 mg/day were compared in a 2022 meta-analysis.
EGCG (food supplements): Mean daily EGCG intake from green tea infusions ranges from 90 to 300 mg/day, with high-level consumers reaching up to 866 mg/day; food supplements provide 5–1,000 mg/day.

8. Safety Considerations and Notable Interactions

Safety of Infusions at Customary Intake

The EFSA Panel concluded that catechins from green tea infusion, prepared in a traditional way and reconstituted drinks with an equivalent composition to traditional green tea infusions, are in general considered to be safe according to the presumption of safety approach, provided the intake corresponds to reported intakes in European Member States.

Hepatotoxicity Risk (Concentrated Extracts)

A formally recognized safety concern for green tea catechins — relevant to concentrated supplement forms rather than standard infusions — is hepatotoxicity. The EFSA panel considered the possible association between the consumption of EGCG and hepatotoxicity. Camellia sinensis is included in the EFSA 'Compendium of botanicals' reported to contain naturally occurring substances of possible concern for human health when used in food supplements, with hepatotoxicity listed as the adverse effect.

However, rare cases of liver injury have been reported after consumption of green tea infusions, most probably due to an idiosyncratic reaction. Based on available data, the EFSA Panel concluded that intake of doses equal to or above 800 mg EGCG/day taken as a food supplement has been shown to induce a statistically significant increase of serum transaminases in treated subjects compared to controls.

EFSA concluded that green tea catechins from green tea infusions prepared in a traditional way are generally considered to be safe; however, rare cases of liver damage have been reported in those who had used supplements containing GTCs called EGCG. EFSA concluded that it was not possible to identify an EGCG dose from GTCs that could be considered safe. In the clinical trials reviewed, there was no evidence of hepatotoxicity below 800 mg EGCG per day for up to 12 months. However, hepatotoxicity was reported for one specific product containing 375 mg EGCG.

EFSA noted that rare cases of liver injury have been reported after consumption of green tea infusions, most probably due to an idiosyncratic reaction. The EFSA Panel noted that the number of human cases with hepatotoxicity associated with green tea infusions is extremely low when compared to the large number of consumers of green tea infusions.

Kukicha, as a whole-plant stem infusion with substantially lower catechin concentrations than standard green tea extracts or supplements, has a correspondingly lower EGCG burden per serving. The hepatotoxicity risk documented in the literature pertains primarily to concentrated green tea extract supplements, not to customary kukicha infusions.

EMA-Identified Contraindications for Green Tea Preparations

The European Medicines Agency (EMA) identified contraindications for use of green tea herbal infusions: hypersensitivity to the active substance(s), gastric and duodenal ulcers, cardiovascular disorders such as hypertension and arrhythmia, and hyperthyroidism. Overdose was considered in the context of caffeine content and can lead to restlessness, tremor, and elevated excitability at quantities corresponding to more than 300 mg of caffeine or 5 cups of tea as a beverage.

Caffeine-Related Effects

According to the NIH, more than five cups per day of green tea is considered "possibly unsafe" due to the side effects of the caffeine. These side effects can range from mild to serious and include headache, nervousness, sleep problems, vomiting, diarrhea, irritability, irregular heartbeat, tremor, heartburn, dizziness, ringing in the ears, convulsions, and confusion. In addition, green tea appears to reduce the absorption of iron from food. Because kukicha contains substantially less caffeine than standard green tea (approximately 20–40 mg per serving versus ~30–50 mg in regular green tea), these caffeine-related adverse effects are less likely at equivalent serving volumes.

Drug Interactions

Warfarin / anticoagulants: Green tea has been proposed to interact with anticoagulant therapy. The most established interaction concerns warfarin, as green tea leaves contain vitamin K, which can antagonize warfarin's inhibition of vitamin K–dependent clotting factors and reduce the INR, particularly when intake changes.
Iron absorption: Green tea also inhibits the absorption of non-heme iron; however, the relationship between habitual green tea consumption and body iron stores has been inconsistently reported. A few studies found that compounds in green tea, including phytates, calcium, tannins, and specific polyphenols, may limit the absorption of nonheme iron, which is already poorly absorbed by the body.
Stimulant medications: While green tea has less caffeine than coffee, it can still interact with other medications that have stimulating effects, such as those used to treat ADHD. When combined with stimulant medications, there can be an additive effect, leading to elevated heart rate, increased blood pressure, anxiety, or insomnia.
Catechin-mediated drug transporter inhibition: Caffeine can speed up central and cardiovascular systems and may affect drugs that act on the brain or heart. Catechins (like EGCG) can change how much of a drug is absorbed from the gut by blocking transport "doors" in the intestines.

Iron Deficiency

Green tea contains tannins and catechins that can bind nonheme iron and reduce absorption, making it harder to correct low iron levels in those with anemia. Given kukicha's lower catechin load compared to full leaf teas, this effect may be attenuated but is not absent.

Special Populations

Traditional Japanese usage includes giving kukicha to children and elderly individuals specifically because of its low caffeine content. Kukicha is widely considered the most caffeine-appropriate Japanese tea for evening drinking, and it is traditionally given to children and elderly people in Japan for exactly this reason. No formal clinical safety data in pediatric or elderly populations specific to kukicha are available in the scientific literature reviewed.